Skip to content

Illumina新闻发布

年 : 2018
日期 标题
2018-11-13 Illumina to Webcast Upcoming Investor Conference Presentations
2018-11-1 Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion, Broadening Access to Long-Read Sequencing and Accelerating Scientific Discovery
2018-10-30 Illumina Launches TruSight Oncology 500 to Power Comprehensive, Accurate, Pan-Cancer Tumor Profiling
2018-10-23 Illumina Reports Financial Results for Third Quarter of Fiscal Year 2018
2018-10-9 Illumina to Announce Third Quarter 2018 Financial Results on Tuesday, October 23, 2018
2018-9-28 Illumina Announces Conversion Period for 0% Convertible Senior Notes due 2019 and 0.5% Convertible Senior Notes due 2021
2018-8-30 Illumina to Webcast Upcoming Investor Conference Presentation
2018-8-27 Illumina Receives Approval of MiSeq™Dx System in China
2018-8-16 Illumina Announces Pricing of Convertible Senior Notes
2018-8-15 Illumina to Offer $650 Million Convertible Senior Notes
2018-7-30 Illumina Reports Financial Results for Second Quarter of Fiscal Year 2018
2018-7-10 Illumina to Announce Second Quarter 2018 Financial Results on Monday, July 30, 2018
2018-5-29 Illumina to Webcast Upcoming Investor Conference Presentations
2018-5-15 Illumina Acquires Edico Genome to Accelerate Genomic Data Analysis
2018-5-2 Illumina to Webcast Upcoming Investor Conference Presentation
2018-4-24 Illumina Reports Financial Results for First Quarter of Fiscal Year 2018
2018-4-13 Bristol-Myers Squibb and Illumina Announce Strategic Collaboration to Develop and Commercialize Companion Diagnostics for Bristol-Myers Squibb’s Oncology Immunotherapies
2018-4-10 Illumina and Loxo Oncology to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics
2018-4-10 Illumina to Announce First Quarter 2018 Financial Results on Tuesday, April 24, 2018
2018-3-12 Illumina Names Dr. Phil Febbo Chief Medical Officer
2018-2-27 Illumina to Webcast Upcoming Investor Conference Presentation
2018-1-30 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2017
2018-1-26 Illumina Awarded $26.7M in Patent Suit Against Ariosa Diagnostics, Inc.
2018-1-16 Illumina to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on Tuesday, January 30, 2018
2018-1-8 Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology
2018-1-8 Illumina Launches iSeq 100 Sequencing System
2018-1-4 Illumina and KingMed Diagnostics Partner to Develop Next-Generation Sequencing Technology for Chinese FDA Approval